Cyncron and BaseCon Form Strategic Partnership in Drug Safety IT Solutions

Cyncron, a Contract Research Organization, and BaseCon, a drug safety IT solutions provider, have agreed on a strategic partnership. Together Cyncron and BaseCon will offer drug safety solutions to the biotech companies in southern Sweden and the Copenhagen region.

Cyncron has chosen to offer BaseCon's web-based IT products and services to their current and future clients. The systems can handle the registration and reporting of Adverse Events, both in connection with clinical trials and post marketing products. The solutions are web-based and hence accessible 24/7. The system is compliant with EMEA and US FDA regulations and guidelines for GxP related activities.

With BaseCon's systems the client gains access to a validated and EMEAi and US FDA compliant drug safety database without having to install specific computer systems or applications software in-house. Because BaseCon's software is web-based BaseCon takes care of all updates and backup routines. Cyncron will use the databases on behalf of their clients in order to provide efficient, compliant and effortless service.

- Cyncron customers will gain great advantages from the flexibility of this web-based solution. It suits both small and medium sized companies perfectly. The handling of Serious Adverse Events is normally a very costly procedure, but with this partnership it is possible to scale the solution which makes it both cost efficient and compliant with applicable GxP regulations, says Bjarne Bodin, VP Biometrics & Medical Affairs, Cyncron.

Read the full press release.

Source: Press release, Cyncron, 07.08.2008